Holen Sie sich die Stockscreener-App
117.79
3.15%
3.5849
Schlusskurs vom Vortag:
$114.21
Offen:
$115.05
24-Stunden-Volumen:
286.09K
Relative Volume:
0.43
Marktkapitalisierung:
$3.81B
Einnahmen:
$747.14M
Nettoeinkommen (Verlust:
$-44.55M
KGV:
-83.50
EPS:
-1.4108
Netto-Cashflow:
$34.52M
1W Leistung:
-0.75%
1M Leistung:
-11.92%
6M Leistung:
-31.50%
1J Leistung:
+12.54%
1-Tages-Spanne:
$113.33
$119.24
1-Wochen-Bereich:
$113.33
$124.40
52-Wochen-Spanne:
$92.52
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Holdings Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
117.75 | 3.69B | 747.14M | -44.55M | 34.52M | -1.4108 |
ABT
Abbott Laboratories
|
102.51 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.77 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.69 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Holdings Inc Aktie (IRTC) Neueste Nachrichten
Data Presented at ACC.26 Demonstrate Benefits of iRhythm's Zio Ambulatory ECG Portfolio - National Today
Data presented at ACC.26 further demonstrate the benefits of iRhythm's Zio ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - bitget.com
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform - The Manila Times
Studies found frequent arrhythmias in diabetes, kidney and obesity patients - Stock Titan
Free cash flow per share of iRhythm Holdings, Inc. – LSE:0A7L - TradingView
Analyzing SOPHiA GENETICS (NASDAQ:SOPH) and iRhythm Technologies (NASDAQ:IRTC) - Defense World
iRhythm Holdings, Inc. (IRTC) reports $5.6M net income, 70.9% gross margin in Q4 2025 - MSN
Jason Patten Joins iRhythm Holdings’ Board of Directors - Medical Product Outsourcing
Vanguard lists zero holdings in iRhythm (NASDAQ: IRTC) - Stock Titan
Assenagon Asset Management S.A. Grows Stock Position in iRhythm Technologies $IRTC - MarketBeat
Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC) - MSN
Q4 Patient Monitoring Earnings Review: First Prize Goes to iRhythm (NASDAQ:IRTC) - Yahoo Finance
[SCHEDULE 13G] iRhythm Holdings, Inc. Passive Investment Disclosure (>5%) - Stock Titan
IRTC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
This Specialized Heart Monitor Maker Just Caught the Eye of a Major Healthcare Fund - The Globe and Mail
This leading manufacturer of specialized heart monitors has recently attracted the attention of a prominent healthcare investment fund. - Bitget
iRhythm (IRTC) director granted 2,218 RSUs vesting from 2027 - Stock Titan
Director Jason H. Patten reports initial holdings in iRhythm Holdings (IRTC) - Stock Titan
How Investors Are Reacting To iRhythm Holdings (IRTC) Adding UnitedHealth Strategy Executive To Its Board - Sahm
iRhythm Holdings, Inc. (IRTC) Q4 earnings and revenues beat estimates - MSN
Insider Sell: Mervin Smith Sells Shares of iRhythm Holdings Inc (IRTC) - GuruFocus
iRhythm (NASDAQ: IRTC) EVP sells 2,585 shares under 10b5-1 plan - Stock Titan
Holocene Advisors LP Buys 160,186 Shares of iRhythm Technologies $IRTC - MarketBeat
iRhythm appoints UnitedHealth executive to board - Investing.com Nigeria
Proposed sale of 2,585 performance shares by Mervin Smith (IRTC) - Stock Titan
Cinctive Capital Management LP Takes $4.82 Million Position in iRhythm Technologies $IRTC - MarketBeat
Algert Global LLC Increases Stake in iRhythm Technologies $IRTC - MarketBeat
A Look At iRhythm Holdings (IRTC) Valuation After Recent Share Price Weakness - simplywall.st
Final Deadline Approaching on April 2, 2021: Kessler Topaz Meltzer & Check, LLP Reminds iRhythm Technologies, Inc. Investors of Class Action Lawsuit Deadline - marketscreener.com
iRhythm Technologies (NASDAQ:IRTC) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is It Time To Revisit iRhythm Holdings (IRTC) After The Recent Share Price Slide? - simplywall.st
iRhythm appoints UnitedHealth executive to board By Investing.com - Investing.com Australia
Irhythm Technologies appoints Jason Patten to board - The Globe and Mail
Latest IRTC NewsiRhythm Technologies to Report Second Quart... - Stock Titan
Schroder Investment Management Group Has $27.81 Million Position in iRhythm Technologies $IRTC - MarketBeat
iRhythm Holdings Appoints Jason Patten to its Board of Directors - Sahm
iRhythm Holdings Appoints Jason Patten to Board of Directors – March 2026 Announcement 6 - Minichart
Jason Patten joins iRhythm (NASDAQ: IRTC) board and audit committee - Stock Titan
Victory Capital Management Inc. Acquires 18,053 Shares of iRhythm Technologies $IRTC - MarketBeat
Mackenzie Financial Corp Sells 274,552 Shares of iRhythm Technologies $IRTC - MarketBeat
iRhythm Holdings (IRTC) Sees Price Target Lowered by Citigroup | - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Price Target Cut to $214.00 by Analysts at Citigroup - MarketBeat
Finanzdaten der Irhythm Holdings Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):